Published in
Taylor and Francis Group, Leukemia & Lymphoma, 4(64), p. 846-855, 2023
DOI: 10.1080/10428194.2023.2173523
Links
Tools
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease
Journal article published in 2023 by
Khaled Sanber 
,
Kevin Ye,
Hua-Ling Tsai,
Matthew Newman,
Jonathan A. Webster ,
Ivana Gojo,
Gabriel Ghiaur,
Gabrielle T. Prince,
Lukasz P. Gondek,
B. Douglas Smith,
Mark J. Levis,
Amy E. DeZern,
Alexander J. Ambinder,
William B. Dalton ,
Tania Jain
,
Kevin Ye,
Hua-Ling Tsai,
Matthew Newman,
Jonathan A. Webster ,
Ivana Gojo,
Gabriel Ghiaur,
Gabrielle T. Prince,
Lukasz P. Gondek,
B. Douglas Smith,
Mark J. Levis,
Amy E. DeZern,
Alexander J. Ambinder,
William B. Dalton ,
Tania Jain
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 